How smarter inventory alignment can reduce risk and strengthen supply chain performance.
The Hidden Cost of Inventory Imbalance
read more
BLOG
The Next Generation of Patient Support
Healthcare is evolving rapidly, and patient support programs must keep pace.
CMS BFSF Rule: Critical Changes Every Pharma Company Must Address
Manufacturers must now submit ASP data with FMV documentation and BFSF fee certification for Medicare Part B drugs.
Self-Injection Training & Patient Success
Practical, hands-on self-injection training plays a pivotal role in ensuring proper medication use and driving positive patient outcomes.
Navigating Pharmacy Types for Commercialization Success
The pharmaceutical market is evolving fast, and delivering prescriptions efficiently is more challenging than ever. The right pharmacy dispensing strategy can be the difference maker between commercial success and missed opportunities.
Evolving Pharma: How DTC/DTP and Telemedicine are Redefining the Industry’s Future
By understanding DTC, DTP and the intersection with telemedicine, pharma can deliver more value to patients and drive measurable results.
From Roadblocks to Runways: Aligning Services for a Smooth Patient Journey
Proven strategies for mapping and optimizing the patient journey, from diagnosis to ongoing care.
The Rise of Digital Health and Technology Integration in the Pharmaceutical Industry
In 2025, digital health is no longer a future consideration—it is a present imperative for key industry players in the pharmaceutical services sector, including manufacturers, specialty pharmacies, payers, and providers
Navigating the Complex World of Pharmaceutical Returns Processing
Efficiently managing product returns is a critical lever for controlling costs, minimizing operational inefficiencies, and reducing end-to-end complexity.
Revolutionizing Patient Support: Creating a Seamless, Patient-Centered Experience
Building a coordinated access model is no longer just a difference – it’s a competitive necessity.
Understanding Fair Market Value
Why It Matters and How Archbow Consulting Can Help You Navigate It
Revolutionizing Patient Support: The Core Pillars of a Seamless Product Access Framework
A well-designed framework ensures that every step is appropriately structured to eliminate unnecessary delays.
Revolutionizing Patient Support: The Power of a Seamless Product Access Framework
Why Understanding the Product Access Journey is Essential for Patient Support Success
2025 Market Access Forecast: Four Game-Changing Trends Reshaping Pharma
Four Pivotal Trends Revolutionizing Market Access Strategies
Fair Market Value vs. Current Market Leverage
How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services
Archbow Consulting: A Committed Partner to NASP
As the only national nonprofit organization representing all specialty pharmacy stakeholders, NASP plays a crucial role in advancing the specialty pharmacy field.
ECRM 2025: Key Trends & Opportunities
Uncovering insights in the pharmaceutical industry, including optimizing supply chain solutions and refining market access strategies.
Revolutionizing Patient Care: The Top 5 Benefits of Investing in Innovation
Why manufacturers must embrace innovative trends to stay ahead
Key Takeaways from NASP 2024
The 2024 National Association of Specialty Pharmacy (NASP) conference showcased a landscape of rapid innovation and evolving industry trends.
Digital Solutions in Patient Services
An Interview on Best Practices and Trends in 2025
Managing Your Network: Are Your Specialty Pharmacies Meeting Program Expectations?
Discover four essential strategies manufacturers need to transform their Specialty Pharmacy networks into efficient powerhouses to enhance patient care, foster innovative HCP relationships, build robust payer partnerships, and ensure product accessibility.
Designing a Pharma Hub for Combination Products
Designing a pharmaceutical hub for combination or companion products is a complex undertaking that requires careful planning and design execution.
Differentiate Your Specialty Pharmacy: A Blueprint for a Valuable Partnership with Pharma Manufacturers
Pharmaceutical manufacturers have many partner choices in today’s competitive Specialty Pharmacy (SP) space. By focusing on the following key areas, SPs can elevate their value proposition and drive mutual success.
How To Maximize Biotech Vendor Marketing
Biotech marketing requires a unique blend of scientific expertise, strategic planning, and creative execution.
Keep Your Planning in the Driver’s Seat: Review Your 2025 Patient Services Strategy Now
Navigate the open road ahead with confidence. Start planning today and ensure your 2025 program delivers the support your patients need.
Key Market Access Trends to Watch in 2024
Key Market Access Trends to Watch in 2024
Don’t Let Your Pharma Program Fall Behind – Optimize It Now
Don’t Let Your Pharma Program Fall Behind – Optimize It Now
The Key to Pharmaceutical Commercial Success
The Key to Pharmaceutical Commercial Success
Outlook on Oncology: Key Takeaways from the AVBCC 2023 Educational Summit
Outlook on Oncology: Key Takeaways from the AVBCC 2023 Educational Summit
Case Study: Fresh Approach to HUB Communications Drives 20% User Growth
Case Study: Fresh Approach to HUB Communications Drives 20% User Growth
Webinar Archive: Pharmaceutical HUBs are Underutilized; Yours Doesn’t Have to Be
HUBs are Underutilized; Yours Doesn’t Have to Be
Key Takeaways from the Health Systems & Pharma Partnering Summit 2023
Key Takeaways from the Health Systems & Pharma Partnering Summit 2023
Risk vs. Reward: A Must-Have Contracting Guide for Specialty Pharmacy Services
Risk vs. Reward: A Must-Have Contracting Guide for Specialty Pharmacy Services
Five Takeaways from Medicare’s 10 Drugs Up for Price Negotiation
Five Takeaways from Medicare’s 10 Drugs Up for Price Negotiation
Pharma Has a Pull-Through Problem; The Answer is Data
Pharma Has a Pull-Through Problem; The Answer is Data
Are Alternative Distribution Models a Viable Option for Pharma?
As seen in Pharmaceutical Commerce: Key considerations for drug manufacturers pursuing an effective alternative distribution model
The Perils of Pull-Through
The Perils of Pull-Through
6 Essential Strategies for Successful Clinical Adherence
6 Essential Strategies for Successful Clinical Adherence
Using Targeted Market Research to Improve Future Adoption of Cell and Gene Therapies
Using Targeted Market Research to Improve Future Adoption of Cell and Gene Therapies
How Pharma Can Turn Data into Insights: Effectively Leveraging Pharma and Market Access Data
How Pharma Can Turn Data into Insights: Effectively Leveraging Pharma and Market Access Data
Market Access POV: ICER and Specialty Drug Coverage
Market Access POV: ICER and Specialty Drug Coverage
Good vs. Excellent: How to Maximize Your 3PL Partnership
Good vs. Excellent: How to Maximize Your 3PL Partnership
Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit
Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit
How Manufacturers Can Optimize Hub Services
How Manufacturers Can Optimize Hub Services
Specialty Pharmacy Services Fair Market Value Benchmark Report
Specialty Pharmacy Services Fair Market Value Benchmark Report
Conversation Starters to Drive Impactful Discussions with Specialty Pharmacies
Conversation Starters to Drive Impactful Discussions with Specialty Pharmacies
3PL Health Checks Generate Savings for Manufacturers: Here’s How to Begin
3PL Health Checks Generate Savings for Manufacturers: Here’s How to Begin
3 Market Access Takeaways from SXSW 2023
What market access teams should be thinking about after 2023’s SXSW Conference
Well-designed Access and Affordability Programs can be a Key Differentiator for Pharma Companies
Manufacturers recognize access and affordability programs as key differentiators that build brand loyalty with elevated customer experiences
Effectively Navigate the Rapidly Evolving Pharmacy Market
Manufacturers recognize access and affordability programs as key differentiators that build brand loyalty with elevated customer experiences
How Effective Product Distribution Strategies Maximize the Pharmaceutical Supply Chain
How pharmaceutical manufacturers can efficiently and effectively get product into the hands of patients
Webinar Archive: 11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
Webinar Archive: Get answers to the eleven key questions that will help guide commercial teams in effectively launching specialty products.
Best Practices for Improving Program Performance Through Well-Managed SP Relationships
With a carefully crafted approach, SPs & Manufacturers can enjoy partnerships that drive access, adherence, and overall program performance
Control vs. Access: Why Clinical Characteristics Should Guide Specialty Pharmacy Strategy
When it comes to pharmacy network design, there is a careful balance between access and control.
How Equitable is Your Pharmacy Dispensing Strategy?
Pharmacy dispensing network strategies are an essential linchpin in any product’s commercial success.
How to Prepare for DSCSA D-Day
For manufacturers who haven’t started preparing for DSCSA D-Day, the “OH NO!” moment is here, but this article can help.
Effective and Practical Ways to Impact Health Inequity Now
Practical lists of questions spanning distribution, access, and affordability that market access teams can use to impact health equity today
11 Market Access Questions to Address Prior to Launching Your First Specialty Drug
The answers to these eleven questions will help guide commercial teams in effectively launching specialty products.
How Quality in Patient Services Programs Can be a Powerful Differentiator for Pharma and Biotech
Poor quality within a HUB can lead to delays in patient treatment, loss of prescriber confidence, and users seeking alternative avenues.
Maximizing Specialty Pharmacy Contracts
When approached strategically, contracting with SP networks can positively impact patient experience and the company’s bottom line.
What the CMS Final Rule on Copay Programs Means for Pharmaceutical Manufacturers
It is vital for pharmaceutical manufacturers to consider how much financial and reputational risk they may face as a result of the pending C
Rare Disease Resources Every Pharma and Biotech Company Should Know
We often advise our clients that there are many varied ways to better understand and engage with rare disease patients.